Plain-English translation of NCT05785832 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tested a newer insulin pump called the t:slim X2 with Control-IQ+ technology in adults with type 2 diabetes who were using insulin injections. The study compared this automated pump system against continuing with traditional insulin injections, to see if the pump helped people keep their blood sugar levels more stable and improved their overall diabetes control.
Many people with type 2 diabetes struggle to keep their blood sugar in a healthy range using insulin injections alone. This medication aims to take some of the guesswork out of managing insulin by automatically adjusting doses throughout the day, which could make diabetes management easier and safer.
Participants were randomly assigned to one of two groups for 13 weeks. Half received the t:slim X2 insulin pump with Control-IQ+ technology and a continuous glucose monitor, while the other half continued using their regular insulin injections with a study glucose monitor. Both groups attended clinic visits to have their blood sugar control checked and to participate in meal and exercise challenges to test how well the systems worked.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
United States